Average Co-Inventor Count = 4.73
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim International Gmbh (32 from 1,535 patents)
2. Boehringer Ingelheim Pharma Gmbh & Co Kg (7 from 194 patents)
3. Boehringer Ingelheim Pharma Kg (2 from 149 patents)
4. Evotec International Gmbh (1 from 13 patents)
42 patents:
1. 12433897 - Pyridine derivatives with n-linked cyclic substituents as cGAS inhibitors
2. 12043625 - Pyridine derivatives with c-linked cyclic substituents as cGAS inhibitors
3. 10793522 - Sulfonamides as inhibitors of the uptake of extracellular citrate
4. 10221202 - Annelated phenoxyacetamides
5. 10155749 - Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
6. 10093660 - Sulfoximine substituted quinazolines for pharmaceutical compositions
7. 9981954 - 2-(pyrazin-2-ylcarbonylaminomethyl) benzimidazolium compounds as epithelial sodium channel inhibitors
8. 9938256 - Annelated benzamides
9. 9932324 - Substituted benzimidazolium compounds useful in the treatment of respiratory diseases
10. 9920035 - Heterocyclic compounds, medicaments containing said compounds, use thereof and processes for the preparation thereof
11. 9328131 - Benzimidazolium compounds
12. 9126982 - Heterocyclic compounds, medicaments containing them, use and processes for the preparation thereof
13. 9126985 - Tetra- and pentasubstituted benzimidazolium compounds
14. 9078909 - Tertiary amines, medicaments containing said amines, use thereof and processes for the preparation thereof
15. 9073954 - 5-substituted benzimidazolium compounds